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Cdc2 Kinase Directly Phosphorylates the cis-Golgi
Matrix Protein GM130 and Is Required for Golgi
Fragmentation in Mitosis
convert the cisternal core into tubular networks that
ultimately fragment, generating heterogenous tubules
and vesicles larger in size than COPI vesicles (Misteli
and Warren, 1995b). The COPI-mediated fragmentation
is linked to the mitotic inhibition of intra-Golgi transport.
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COPI vesicles are believed to accumulate in mitosis²Protein Sequencing Laboratory
because they continue tobud, but no longer dock or fuseImperial Cancer Research Fund
with their target membrane, and therefore accumulate.44 Lincoln's Inn Fields
Recent experiments have revealed a potential molec-London, WC2A 3PX
ular mechanism for the mitotic inhibition of COPI vesicleUnited Kingdom
docking. The vesicle-docking protein p115 is required³The Wellcome/CRC Institute
for intra-Golgi transport (Waters et al., 1992) and hasTennis Court Road
also been implicated in docking of transcytotic vesiclesCambridge, CB2 1QR
with the plasma membrane (Barroso et al., 1995). It isUnited Kingdom
a parallel homodimer with two globular heads and a
coiled-coil tail (Barroso et al., 1995; Sapperstein et al.,
1995). p115 is required for docking COPI vesicles toSummary
Golgi membranes in vitro (SoÈ nnichsen et al., 1998). Ge-
netic and biochemical analyses have shown that the
Mitotic fragmentation of the Golgi apparatus can be yeast homolog Uso1p docks transport vesicles at a step
largely explained by disruption of the interaction be- upstream of SNARE complex formation (Sapperstein et
tween GM130 and the vesicle-docking protein p115. al., 1996; Cao et al., 1998). This, together with its elon-
Here we identify a single serine (Ser-25) in GM130 gated shape, has led to the proposal that p115/Uso1p
as the key phosphorylated target and Cdc2 as the initially binds (tethers) the vesicle to its target membrane
responsible kinase. MEK1, a component of the MAP in a step preceding SNARE pairing (Pfeffer, 1996). While
kinase signaling pathway recently implicatedin mitotic p115 can bind to COPI vesicles under both interphase
Golgi fragmentation, was not required for GM130 phos- and mitotic conditions (SoÈ nnichsen et al., 1998), its bind-
phorylation or mitotic fragmentation either in vitro or ing to Golgi membranes is significantly inhibited in mito-
in vivo. We propose that Cdc2 is directly involved in sis (Levine et al., 1996; Shima et al., 1997). This is be-
mitotic Golgi fragmentation and that signaling via cause it can no longer bind its Golgi membrane receptor,
MEK1 is not required for this process. GM130, a tightly associated peripheral membrane pro-
tein originally identified as a component of a Golgi matrix
(Nakamura et al., 1995, 1997). GM130 is mitotically phos-
Introduction phorylated (Nakamura et al., 1997; Sohda et al., 1998),
and when this occurs, p115 can no longer bind (Naka-
The Golgi apparatus of mammalian cells has a distinc- mura et al., 1997). This is believed to prevent docking
tive morphology during interphase, comprising a ribbon of COPI vesicles and so explains the inhibition of trans-
of stacked flattened cisternae with cis- and trans-Golgi port and the COPI-mediated fragmentation of Golgi cis-
networks on either face of the stack (Rambourg and ternae in mitosis.
Clermont, 1990). In mitosis, this organization is dramati- Passage through the eukaryotic cell cycle requires
cally altered. The Golgi ribbon is first broken up into the successive activation of different cyclin-dependent
many individual stacks that then fragment further, yield- kinases (CDKs) (reviewed by Nigg, 1995). The transition
ing clusters of vesicles and tubules (Misteli and Warren, from G2 to M phase is controlled by Cdc2, which forms
1995a). Mitotic Golgi fragmentation has been exten- complexes with cyclins of the A and B families. Cdk2,
which is predominantly active at the G1±S transition andsively studied morphologically in vivo and can be mim-
in S phase, appears also to play a role in regulatingicked in a cell-free system by incubating purified Golgi
entry into mitosis, since it can act as a positive regu-membranes with cytosol prepared from mitotic HeLa
lator of cyclin B±Cdc2 (Guadagno and Newport, 1996).cells (Misteli and Warren, 1994). This has led to the
Cdc2 is responsible for many of the cellular reorganiza-definition of two principal fragmentation pathways. The
tions that take place at the onset of mitosis, such asCOPI-mediated pathway likely consumes the cisternal
chromosome condensation, disassembly of the nuclearrims, giving rise to numerous COPI-coated vesicles
lamina, and formation of a mitotic spindle (Nigg, 1995).(Misteli and Warren, 1994). This pathway accounts for
Studies on Golgi fragmentation showed that this pro-about two-thirds of cisternal membrane. The remaining
cess is also dependent upon Cdc2 (Misteli and Warren,Golgi membrane is consumed by the less-well charac-
1994). Similarly, activation of Cdc2 but not Cdk2 wasterized COPI-independent pathway, which appears to
shown to inhibit transport between Golgi cisternae
(Mackay et al., 1993; Stuart et al., 1993). However,§To whom correspondence should be addressed.
whether Cdc2 was acting directly or via a downstream‖ Present address: Laboratory of Genetics, Department of Biochem-
kinase was not addressed in these experiments, andistry, South Park Road, Oxford, OX1 3QU, United Kingdom.
the relevant substrates were unknown. Recent findings# Present address: Department of Molecular Biology, Graduate School
of Medical Science, Kyushu University, Fukuoka 812±82, Japan. have led to the suggestion that Cdc2 does not directly
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Figure 1. Phosphorylation of GM130 by Cdc2
(A) Immunodepletion of Cdk2 and Cdc2 from
mitotic cytosol. Mitotic cytosol (lane 1) was
incubated with beads coupled to antibodies
against Cdk2 (lane 2), Cdc2 (lane 3), or control
antibodies (lane 4). Unbound cytosolic pro-
teins were immunoblotted with anti-Cdk2 or
anti-Cdc2 antibodies (top) or assayed for his-
tone kinase activity (bottom).
(B) Phosphorylation of GM130 with depleted
cytosols. The N-terminal peptide of GM130
(N73pep; top) or salt-washed Golgi mem-
branes (bottom) were incubated in the pres-
ence of [g-32P]ATP with buffer (lane 1), mitotic
cytosol (lane 2), mock-depleted cytosol (lane
5), or mitotic cytosol depleted of Cdk2 (lane
3) or Cdc2 (lane 4). In a separate experiment,
incubations were performed with mock-
depleted cytosol (lane 6), Cdc2-depleted cy-
tosol (lane 7), or Cdc2-depleted cytosol sup-
plemented with purified recombinant cyclin
B1±Cdc2 added to the same histone kinase
activity as the mock-depleted sample (lane
8). N73pep was analyzed by SDS-PAGE and
autoradiography (top). GM130 was immuno-
precipitated from solubilized Golgi mem-
branes before SDS-PAGE and autoradiogra-
phy (bottom).
(C) Phosphorylation of N73pep with purified
recombinant kinases. N73pep was incubated
in the presence of [g-32P]ATP with either
buffer alone (lane 1), mitotic cytosol (lane 2),
purified cyclin A±Cdk2 (lane 3), cyclin E±Cdk2
(lane 4), or cyclin B1±Cdc2 (lane 5). In a sepa-
rate experiment, incubations were performed
with mitotic cytosol (lane 6) or cyclin B2±Cdc2
(lane 7). The amounts of kinase were normal-
ized for their activity against histone H1. Pro-
teins were analyzed by SDS-PAGE and auto-
radiography.
(D) Phosphorylation of GM130 on Golgi mem-
branes with purified recombinant kinases.
Salt-washed Golgi membranes were incu-
bated in the presence of [g-32P]ATP with ei-
ther buffer alone (lane 1), mitotic cytosol (lane
2), purified cyclin E-cdk2 (lane 3), or cyclin
B1±Cdc2 (lane 4). Equivalent levels of histone
kinase activity wereused in each case.After solubilizationof the membranes, GM130was immunoprecipitated and detectedby autoradiography.
(E) Phosphopeptide mapping of GM130. GM130 was immunoprecipitated from 32P-labeled mitotic NRK cells (left) or from salt-washed Golgi
membranes phosphorylated in vitro using cyclin B1±Cdc2 in the presence of [g-32P]ATP (middle). N73pep was phosphorylated in vitro
using mitotic cytosol and [g-32P]ATP (right). After SDS-PAGE and tryptic digestion, phosphopeptides were separated in two dimensions by
electrophoresis followed by chromatography and detected by autoradiography. The origin is at the bottom left corner. The major phosphopep-
tide is labeled with the letter ªaº and the minor ones with ªbº and ªc.º
participate in Golgi fragmentation, but rather acts through First, the specific CDK inhibitor olomuocine prevented
GM130 phosphorylation in vitro (Nakamura et al., 1997).MEK1, a component of the MAP kinase signaling path-
way (Acharya et al., 1998). It was proposed that MEK1 Second, removal of CDKs from mitotic cytosol using
p13suc1 beads abolished GM130 phosphorylation (dataphosphorylates and activates a putative novel ERK on
Golgi membranes, which then phosphorylates Golgi- not shown). To identify the GM130 kinase, we took ad-
vantage of these findings and used specific antibodiesspecific targets to bring about disassembly in mitosis.
In this paper, we now show that GM130 can be directly to deplete the two CDKs known to play a role in the
initiation and progression of mitosis, Cdc2 and Cdk2,phosphorylated by Cdc2 kinase. Furthermore, we pro-
vide evidence that Cdc2 activity is essential for mitotic from mitotic cytosol. The efficiency of depletion was
shown by immunoblotting to be greater than 95% (Fig-Golgi fragmentation, while MEK1 is not essential for this
process either in vitro or in vivo. ure 1A, top). Depletion of Cdc2 removed more than 90%
of the histone kinase activity (Figure 1A, bottom). The
depleted cytosols were tested for their ability to phos-Results
phorylate a synthetic peptide corresponding to the N-ter-
minal 73 amino acids of GM130 (N73pep). This peptideGM130 Is Phosphorylated by Cdc2 Kinase
Two lines of evidence suggested that a CDK was re- contains the p115-binding site and is efficiently phos-
phorylated by mitotic cytosol in vitro (Nakamura et al.,sponsible for the mitotic phosphorylation of GM130.
Cdc2 in Golgi Fragmentation
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1997). Depletion of Cdk2 had no effect upon phosphory-
lation of the GM130 peptide (Figure 1B, top, lane 3),
while phosphorylation was almost completely abolished
by depletion of Cdc2 (Figure 1B, top, lane 4). The kinase-
depleted cytosols were also tested for their ability to
phosphorylate native GM130 on Golgi membranes. Na-
tive GM130 was phosphorylated to a similar extent by
Cdk2-depleted, mock-depleted, and untreated mitotic
cytosol (Figure 1B, bottom, lanes 2, 3, and 5), while
very little phosphorylation was observed with the Cdc2-
depleted cytosol (Figure1B, bottom, lane 4). Phosphory- Figure 2. Phosphorylation of GM130 by Cdc2 Regulates Binding to
lation of both N73pep and native GM130 was restored p115
when purified recombinant cyclin B1±Cdc2 was added Left panel, salt-washed Golgi membranes were incubated with ei-
to the Cdc2-depleted cytosols to give the same histone ther buffer alone (lane 1), mitotic cytosol (lane 2), mock-depleted
kinase activity as mock-depleted cytosol (Figure 1B, cytosol (lane 5), or cytosol depleted of Cdk2 (lane 3) or Cdc2 (lane
4). Right panel, salt-washed Golgi membranes were incubated withlanes 6±8).
either buffer alone (lane 1), mitotic cytosol (lane 2), purified cyclinThe converse experiments were also carried out using
E-cdk2 (lane 3), or cyclin B1±Cdc2 (lane 4). After solubilization of thehighly purified recombinant kinases. The GM130 peptide
membranes, proteins were incubated with p115 beads and bound
was incubated with [g-32P]ATP and either buffer alone, GM130 detected by immunoblotting.
mitotic cytosol, purified cyclin A±Cdk2, cyclin E±Cdk2,
cyclin B1±Cdc2, or cyclin B2±Cdc2. The amounts of
did not bind (lanes 2, 3, and 5). In contrast, GM130kinase added were normalized using histone H1 as a
treated with Cdc2-depleted cytosol bound efficiently tosubstrate. Cdc2 complexed to either cyclin B1 or B2
the p115 beads (lane 4). This strongly suggests thatphosphorylated the GM130 peptide at a similar rate (not
Cdc2-mediated phosphorylation of GM130 regulatesshown) and to a similar level as mitotic cytosol (Figure
p115 binding. This was confirmed by incubating salt-1C; compare lane 5 with lane 2 and lane 7 with lane 6).
washed Golgi membranes with purified CDKs and ana-In contrast, there was no significant phosphorylation
lyzing the ability of GM130 to bind p115. As shown inof the peptide by Cdk2, irrespective of whether it was
Figure 2, treatment with mitotic cytosol or cyclin B1±complexed tocyclin Eor A (Figure1C, lanes 3 and 4). The
Cdc2 inhibited binding to p115 (lanes 7 and 9), whileability of the purified kinases to phosphorylate native
cyclin E±Cdk2 had no effect (lane 8). Similar results wereGM130 on Golgi membranes was also tested. As shown
obtained with in vitro±synthesized recombinant GM130in Figure 1D, GM130 was phosphorylated by cyclin B1±
(not shown).Cdc2 (lane 4) to a level comparable to mitotic cytosol
(lane 2) but not by cyclin E±Cdk2 (lane 3).
GM130 Is Phosphorylated on Serine 25If Cdc2 is the mitotic GM130 kinase, it should phos-
The consensus motif for Cdc2 is Ser/Thr-Pro-X-Arg/Lys,phorylate GM130 at the same sites in vitro as those
with Pro at the 11 position absolutely critical, and aphosphorylated in mitotic cells. To investigate this,
basic residueat the 13 position preferred but not essen-GM130 was immunoprecipitated from 32P-labeled mi-
tial for kinase recognition (Songyang et al., 1994; Holmestotic NRK cellsand subjected to two-dimensional tryptic
and Solomon, 1996). There are three Ser and no Thrphosphopeptide mapping. The resulting pattern revealed
residues with Pro at the 11 position, all close to the None major phosphopeptide (spot a) and two poorly re-
terminus of rat GM130, the region we previously identi-solved minor phosphopeptides (spots b and c) (Figure
fied as the p115-binding site (Figure 3A). Phospho-1E, left). When GM130 was immunoprecipitated from
amino acid analysis of mitotically phosphorylated GM130Golgi membranes phosphorylated in vitro with purified
showed that it is phosphorylated exclusively on Ser resi-cyclin B1±Cdc2, a very similar pattern was obtained
dues (data not shown). Since N73pep was efficiently(Figure 1E, middle). This strongly suggests that GM130
phosphorylated by mitotic cytosol in vitro, we reasonedis phosphorylated at the same sites by Cdc2 in vitro
that the major phosphorylation site of GM130 would lieas those phosphorylated in vivo, consistent with Cdc2
in this region, which has two SP motifs. To determinephosphorylating GM130 in mitotic cells.
if this was the case, N73pep was phosphorylated using
mitotic cytosol and subjected to two-dimensional tryptic
phosphopeptide mapping. This gave rise to one majorPhosphorylation of GM130 by Cdc2 Inhibits
Binding to p115 phosphopeptide (spot a) at the same position as the
major phosphopeptide of the full-length GM130 proteinWe have previously shown that mitotic phosphorylation
of GM130 prevents binding to the vesicle-docking pro- (Figure 1E; compare right with left panel), confirming
that the major mitotic phosphorylation site of GM130tein p115 (Nakamura et al., 1997). To determine whether
the Cdc2-mediated phosphorylation of GM130 can ac- resides within this peptide sequence. To identify the
modified residue, N73pep was phosphorylated by mi-count for this regulation, salt-washed Golgi membranes
were phosphorylated in vitro using the CDK-depleted totic cytosol, proteolytically digested, and mass spec-
trometry performed on the proteolytic fragments. Themitotic cytosols, the membranes were solubilized, and
binding of GM130 to beads containing immobilized p115 mass of these fragments was compared to their pre-
dicted mass without or with one additional phosphatewas analyzed. As shown in Figure 2, untreated GM130
bound to the p115 beads (lane 1), while GM130 treated group (corresponding to a mass increase of 80 Da). As
a control, untreated N73pep was subjected to the samewith mitotic cytosol, Cdk2-, or mock-depleted cytosol
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Figure 3. GM130 Is Phosphorylated on Ser-
ine 25
(A) Alignment of the N-terminal sequences of
human and rat GM130. Identity is represented
by dark shading and conservative changes by
light shading. The three putative Cdc2 sites in
rat GM130 are underlined. Note there is an
additional SP (S53) and TP (T57) in the human
sequence not present in rat GM130.
(B) Mass spectrometry of phosphorylated
N73pep. N73pep was incubated with mitotic
cytosol before SDS-PAGE and transfer to
PVDF membrane. Digestion was performed
with trypsin or V8 protease to generate pep-
tides for mass spectrometry. The amino acid
sequences and predicted masses of the frag-
ments without or with phosphorylation (on the
available SP motifs) are on the left and the
corresponding masses obtained on the right.
Matching calculated and predicted masses
are underlined. SP sequences in each peptide
are boxed and Ser-25 marked with an as-
terisk.
analysis. As shown in Figure 3B, only those fragments performing binding to p115 beads. As expected,binding
of wild-type GM130 was inhibited by preincubation withcontaining Ser-25 had a mass consistent with the pres-
ence of one additional phosphate. This was true for the mitotic cytosol (Figure4B). This was due tophosphoryla-
tion, since binding was not inhibited in the presence ofV8 fragment (residues 20±45) containing both putative
Cdc2 sites, showing the second site (Ser-43) to be un- staurosporine. Mutation of Ser-43 and/or Ser-82 had
little effect upon themitotic regulation of binding to p115phosphorylated. With untreated N73pep, the mass of
each peptide corresponded to that expected for no (Figure 4B). In contrast, mutation of Ser-25 in each of
the constructs had a dramatic effect, GM130 now bind-phosphorylation (not shown). We therefore conclude
that Ser-25 represents the major mitotic phosphoryla- ing p115 under mitotic as well as interphase conditions.
The level of binding of the Ser-25 mutants was similartion site in GM130.
under both conditions, strongly suggesting that Ser-25
is the major residue involved in the mitotic regulation ofPhosphorylation of GM130 on Serine 25
Inhibits Binding to p115 GM1130 binding to p115.
To determine whether modification of Ser-25 can regu-
late binding to p115, it was mutated by site-directed
mutagenesis to either mimic phosphorylation (Ser to Mitotic Golgi Fragmentation Requires Cdc2
If Cdc2-mediated phosphorylation of GM130 is impor-Asp) or prevent phosphorylation (Ser to Ala). The role
of the two other putative Cdc2 sites (Ser-43 and Ser- tant for mitotic Golgi fragmentation, then Cdc2 should
be required for this process. Previous experiments have82) was also addressed by mutating these residues in
the same manner. Wild-type and mutated constructs suggested a role for Cdc2 in mediating mitotic Golgi
fragmentation in a cell-free system (Misteli and Warren,comprising the N-terminalhalf of GM130 were translated
in vitro and their ability to bind p115 analyzed. Golgi 1994). This was achieved by adding cyclin A, which can
bind and activate Cdk2 and Cdc2, to interphase cytosolmembrane proteins were fractionated by SDS-PAGE,
transferred to nitrocellulose, and overlaid with each of to generate a ªpseudo-mitoticº cytosol. It was demon-
strated that cyclin A was acting through Cdc2 and notthe 35S-labeled GM130 constructs. As seen previously
(Nakamura et al., 1997), wild-type GM130 bound to two through Cdk2 to trigger Golgi disassembly. However,
whether Cdc2 was acting directly or through other ki-proteins of 130 kDa and 115 kDa, corresponding to
GM130 and p115, respectively (Figure 4A, lane 1). Muta- nases activated downstream of Cdc2 could not be ad-
dressed in these experiments. We therefore performedtion of Ser-25 to Asp greatly reduced the binding to
p115, while binding to GM130 was unaffected (Figure disassembly experiments using mitotic cytosol immu-
nodepleted of Cdc2, which should contain the full com-4A, lane 3). Binding to p115 was not affected by any of
the other mutations. plement of mitotically active kinases (except Cdc2), in-
cluding kinases activated downstream of Cdc2 itself.We next studied binding of the GM130 mutants to
p115 under interphase and mitotic conditions. The three Importantly, no Cdc2 could be detected on our purified
Golgi membranes (not shown). Cisternal fragmentationputative Cdc2 sites were mutated to Ala separately or
in combination and the corresponding mutant proteins was defined by the loss of cisternal membranes, with
fragmentation induced by mitotic cytosol set to 100%preincubated with interphase or mitotic cytosol before
Cdc2 in Golgi Fragmentation
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Figure 5. Mitotic Golgi Fragmentation in a Cell-Free System Re-
quires Cdc2
Golgi membranes were incubated for 30 min either in buffer alone
on ice (none) or at 378C with interphase, mitotic, mock-depleted or
Cdc2-depleted mitotic cytosol, or Cdc2-depleted mitotic cytosol
plus purified cyclin B1±Cdc2 (added to same histone kinase activity
as the mock-depleted sample). Membranes were then fixed, pro-
cessed, and the percentage membrane in cisternae calculated. Re-
sults are presented as percentage of cisternal fragmentation 6 SEM
(n 5 3±5), where 0% represents starting Golgi membranes (None,
48.8% 6 3% in cisternal membranes) and 100% represents Golgi
membranes after incubation with mitotic cytosol (25.3% 6 2% in
cisternal membranes).
of Cdc2 to bring about disassembly. Since this was at
variance with our findings, we decided to investigate
the role of MEK1 in Golgi fragmentation using our cell-
free assay. We first analyzed the amount of MEK1 in the
Cdc2-depleted cytosol. As shown in Figure 6A, MEK1
was present at a similar level in Cdc2-depleted cytosol
to that present in mitotic and mock-depleted cytosol.
The activity of MEK1 in the Cdc2-depleted cytosol was
Figure 4. Phosphorylation of Serine 25 Inhibits Binding to p115 then measured using an immune complex±based kinase
(A) Golgi membranes (20 mg per lane) were subjected to SDS-PAGE assay (see Experimental Procedures for details). MEK1
and transferred to nitrocellulose. Blots were overlaid with in vitro± activity in Cdc2-depleted cytosol was similar to that
translated 35S-labeled GM130 constructs with the indicated Ser (S)
measured in mitotic and mock-depleted cytosol (Figureto Ala (A) or Asp (D) point mutations and developed by autoradiog-
6B). Preincubation of the Cdc2-depleted cytosol for upraphy.
to 40 min had no effect upon the MEK1 activity, showing(B) 35S-labeled GM130 constructs with the indicated Ser to Ala muta-
that Cdc2 was not required to maintain MEK1 in thetions were incubated with interphase (I), mitotic (M), or mitotic cyto-
sol inactivated with staurosporine (M1St). After addition of stauro- cytosol in an activestate (not shown).We also measured
sporine and microcystin to prevent any further changes in the MEK1 activity in our interphase and mitotic HeLa
phosphorylation, p115 beads were added. Bound proteins were cytosols. As shown in Figure 6B, MEK1 is 2.5-fold less
resolved by SDS-PAGE and detected by fluorography.
active in mitotic compared to interphase cytosol. Mitotic
NRK extracts also had lower MEK1 activity compared
to interphase extracts (not shown). These data already
(Figure 5). Depletion of Cdc2 reduced cisternal fragmen- suggested that MEK1 was not required for mitotic Golgi
tation to 35%, similar to the level observedfor interphase fragmentation in our cell-free assay. To examine this
cytosol (33% fragmentation), while mock depletion had more directly, mitotic cytosol was depleted of MEK1
no significant effect (95% fragmentation) (Figure 5). Ad- using specific antibodies. Immunoblotting confirmed
dition of purified cyclin B1±Cdc2 to the Cdc2-depleted that more than 95% of MEK1 was removed (Figure 6A,
cytosol restored fragmentation to a level similar to mi- lane 3). There was no detectable MEK1 on the purified
totic cytosol (93%), showing that loss of fragmentation Golgi membranes (Figure 6A, lane 6). When tested in
was due to removal of Cdc2 and not some other compo- the cell-free Golgi disassembly assay, MEK1-depleted
nent of the cytosol. Mitotic Golgi fragmentation in vitro cytosol could fragment Golgi membranes to the same
is therefore dependent upon active Cdc2 in the cytosol, extent as mock-depleted and mitotic cytosol (Figure
even though othermitotically activekinases are present. 6D). The disassembly assay was also carried out using
Cdc2-depleted cytosol supplemented with exogenous
MEK1 Is Not Required for Mitotic Golgi activated MEK1 (added at three times the endogenous
Fragmentation In Vitro level). Analysis of MEK1 activity confirmedthat theexog-
It has recently been reported that mitotic Golgi fragmen- enous MEK1 was not inactivated in the assay (not
tation requires MEK1 rather than Cdc2 (Acharya et al., shown). Addition of active MEK1 had no effect upon
Golgi fragmentation (Figure 6D).1998). It was proposed that MEK1 functions downstream
Cell
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Figure 6. Mitotic Golgi Fragmentation in a
Cell-Free System Is Independent of MEK1
(A) Immunoblotting of cytosols and Golgi
membranes for MEK1. Left panel, 20 mg of
mitotic cytosol (lane 1), mock-depleted cyto-
sol (lane 2), or cytosol depleted of MEK1 (lane
3) or Cdc2 (lane 4) was subjected to SDS-
PAGE and MEK1 detected by immunoblot-
ting. Right panel, 20 mg of rat liver cytosol or
purified rat liver Golgi membranes was immu-
noblotted for MEK1.
(B) MEK1 activity of interphase, mitotic, mock-,
and Cdc2-depleted mitotic cytosol. MEK1
was immunoprecipitated from the cytosols
indicated and assayed by activation of ERK2
followed by phosphorylation of MBP by
ERK2. Results are presented as the mean 6
SEM (n 5 2±5).
(C) Inhibition of MEK1 from mitotic cytosol
by PD98059. MEK1 was immunoprecipitated
from mitotic cytosol and assayed by activa-
tion of ERK2 in the absence or presence of
the indicated concentration of PD, followed
by phosphorylation of MBP by ERK2. Results
are presented as the mean 6 SEM (n 5 2±5).
(D) Effects of MEK depletion, active MEK, and
PD98059 upon mitotic Golgi fragmentation in
vitro. Golgi membranes (10 mg) were incu-
bated for 30 min either in buffer alone on ice
(none) or at 378C with the following cytosols
(650 mg cytosolic protein): interphase, mi-
totic, mock-depleted, MEK1-depleted, Cdc2-
depleted mitotic cytosol plus active MEK1
(added to give four times the endogenous
MEK1 activity), and mitoticcytosol pretreated
with 20 mM or 50 mM PD98059. Membranes
were then fixed, processed, and the percent-
age membrane in cisternae calculated. Results are presented as percentage of cisternal fragmentation 6 SEM (n 5 2±3).
(E) Effects of MEK depletion, active MEK, and PD98059 upon GM130 phosphorylation. Salt-washed Golgi membranes were incubated in the
presence of [g-32P]ATP with active MEK1 (added to give eight times the activity of mitotic cytosol; lane 1), mitotic cytosol (lane 2), mock-
depleted (lane 3), or MEK1-depleted cytosol (lane 4). In a separate experiment, incubations were performed with mitotic cytosol preincubated
without (lane 5) or with 50 mM PD (lane 6). After solubilization of the membranes, GM130 was immunoprecipitated and detected by autoradiog-
raphy.
To further investigate the role of MEK1 in Golgi frag- MEK1 also had no discernible effect upon total Golgi
mentation, mitotic cytosolwas pretreated with the highly protein phosphorylation. The pattern and amount of
specific MEK1 inhibitor PD98059 (Alessi et al., 1995; phosphorylation of Golgi proteins obtained using MEK1-
Dudley et al., 1995). This drug blocks the activation of depleted cytosol was indistinguishable from that ob-
MEK1 by Raf or MEKK and can also directly inhibit lower tained with mock-depleted cytosol (not shown).
activity forms of the kinase.Pretreatment of mitotic cyto-
sol for up to 40 min with 50 mM PD had no effect on
MEK1 Is Not Required for Mitotic GolgiMEK1 activity, showing that MEK1 was not being inacti-
Fragmentation In Vivovated and reactivated in the cytosol (not shown). How-
MEK1 is not required for mitotic Golgi fragmentation inever, when PD was present during the MEK1 assay, it
our cell-free assay, while it was required for mitotic frag-significantly decreased MEK1 activity (Figure 6C), show-
mentation in the permeabilized cell system of Acharyaing it could directly inhibit the MEK1 in mitotic cytosol.
et al. (1998). To address this discrepancy and find outPD-treated mitotic cytosol was tested for its ability to
which assay reflects the situation in vivo, we decidedfragment Golgi membranes. Treatment of cytosol with
to investigate whether MEK1 is required for mitotic Golgiup to 50 mM PD had no effect upon mitotic Golgi frag-
fragmentation in intact cells.mentation (Figure 6D). Together these data indicate that
To study the role of MEK1 in mitotic Golgi fragmenta-MEK1 is not required for mitotic Golgi fragmentation in
tion in vivo, we took advantage of the fact that PD98059vitro.
can inhibit MEK1 in intactcells (Alessi etal., 1995; DudleyWe also studied the effects of PD, MEK depletion,
et al., 1995). NRK cells were arrested in S phase usingand active MEK upon phosphorylation of Golgi proteins
aphidicolin, released from the block, and either left un-and in particular GM130. Addition of PD or depletion of
treated or incubated with 50 mM PD for an additional 4endogenous MEK1 from mitotic cytosol had no effect
hr to allow the cells to progress into mitosis. Cells wereupon the in vitro phosphorylation of GM130, and addi-
lysed at 1 hr intervals during this time and the activitytion of active MEK1 to Golgi membranes did not stimu-
late GM130 phosphorylation (Figure 6E). Depletion of of MEK1 assessed by immunoblotting with an antibody
Cdc2 in Golgi Fragmentation
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Figure 7. Mitotic Golgi Fragmentation In Vivo Is Independent of MEK1
(A) PD treatment of mitotic cells. Aphidicolin-arrested NRK cells were washed, incubated for 1 hr, and left untreated or exposed to 50 mM
PD for an additional 4 hr to allow entry into mitosis. Cells were lysed at the times indicated and analyzed by immunoblotting with antibodies
against phosphorylated ERK1 and -2 (ppERK) or total ERK2. The percent mitotic index was calculated by fluorescence microscopy using
Hoechst 33342.
(B) Anthrax toxin treatment of mitotic cells. Aphidicolin-arrested NRK cells were washed, incubated for 1 hr, and left untreated or exposed
to anthrax toxin (1 mg/ml PA and 250 ng/ml LF) for an additional 4 hr to allow entry into mitosis. Cells were lysed at the times indicated and
analyzed by immunoblotting with antibodies against phosphorylated ERK1 and -2 (ppERK), total ERK2, or the N or C terminus of MEK1 [MEK1
(NT) or (CT)].
(C) Immunofluorescence localization of Golgi membranes in PD and anthrax toxin±treated mitotic cells. Aphidicolin-arrested NRK cells were
washed, incubated for 1 hr, and left untreated or exposed to 50 mM PD or anthrax toxin (1 mg/ml PA and 250 ng/ml LF) for an additional 4 hr
to allow entry into mitosis. Cells were fixed and stained with antibodies to GM130. Examples of untreated (control, top), PD- (middle), and
anthrax toxin±treated (bottom) metaphase cells are shown. Bar, 10 mm.
(D) Electron microscopy of mitotic Golgi clusters in PD and anthrax toxin±treated cells. Aphidicolin-arrested NRK cells were washed, incubated
for 1 hr, and left untreated or exposed to 50 mM PD or anthrax toxin (1 mg/ml PA and 250 ng/ml LF) for an additional 4 hr to allow entry into
mitosis. Mitotic cells were collected, fixed, and processed for electron microscopy. Examples of mitotic Golgi clusters from untreated (control,
top), PD- (middle), and anthrax toxin±treated (bottom) metaphase cells are shown. Bar, 0.2 mm.
specific for the phosphorylated forms of ERK1 and -2, into mitosis (not shown). PD had no effect upon mitotic
Golgi fragmentation. Ninety-eight percent of PD-treatedthe two known MEK1 substrates. As shown in Figure
7A, PD abolished the phosphorylation of ERK1 and -2, metaphase cells had a fragmented Golgi, compared to
99% of control metaphase cells (n 5 100 cells). Golgishowing that PD inactivated MEK1 in vivo. Golgi frag-
mentation was studied in the PD-treated cells by immu- fragmentation in PD-treated cells was also studied by
electron microscopy (Figure 7D). PD treatment had nonofluorescence microscopy using antibodies to the
Golgi-marker GM130. Mitotic cells were identified using significant effect upon the number of mitotic Golgi clus-
ters per cell, nor upon the average volume density (VD)the DNA-specific dye Hoechst 33342 and the number
of metaphase cells with a fragmented Golgi scored (see of the clusters. The average number of Golgi clusters
per cell section was 6.1 6 3.1 for PD-treated cells, com-Figure 7C). PD had no effect upon the number of cells
entering mitosis (Figure 7A), demonstrating that MEK1 pared to 6.3 6 3.4 for untreated cells. The average VD of
mitotic Golgi clusters from untreated cells was 0.0016 6is not required for mitotic entry. In contrast, the CDK
inhibitor roscovitine (Meijer et al., 1997) blocked entry 0.001 and from PD-treated cells was 0.0017 6 0.001.
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The role of MEK1 in vivo was examined further using abolish phosphorylation restored binding under mitotic
conditions. Mutation of theother two putative Cdc2 sitesanthrax toxin, which has recently been demonstrated
(Ser-43 and Ser-82) had no discernible effect upon p115to proteolytically inactivate MEK1 in intact cells (Dues-
binding. These data are consistent with competitivebery et al., 1998). Cells released from an S phase arrest
binding experiments that have localized the p115-bind-were either left untreated or incubated with anthrax toxin
ing site to the first 40 amino acids of GM130 (not shown).for a further 4 hr to allow entry into mitosis. Cleavage
This region is extremely well conserved between rat andof MEK1, which results in removal of the N-terminal
human GM130 (93% identity compared to only 38%seven residues, was monitored by immunoblotting with
identity for the next 40 amino acids downstream). Ser-antibodies to the N and C termini of MEK1. As shown
25 therefore resides in a highly conserved region ofin Figure 7B, anthrax efficiently cleaved MEK1 after 2
GM130 that constitutes the minimally defined p115-hr, resulting in loss of reactivity to the N-terminal anti-
binding site, while the other two putative Cdc2 sites liebodies. Probing with antibodies to the C terminus of
outside this region. In addition, Ser-25 and its immediateMEK1 revealed an increased mobility and reduced lev-
flanking residues are 100% conserved between rat andels of antigen after cleavage, as previously observed
human, while Ser-43 and Ser-82 are not. These findings(Duesbery et al., 1998). Immunoblotting with antibodies
support theconclusion that Ser-25alone regulates bind-against phosphorylated ERK1 and -2 showed that MEK1
ing to p115. Further comparison of rat and humanwas inactivated in cells by the anthrax toxin±mediated
GM130 revealed that the human sequence has two po-cleavage (Figure 7B) as expected. Golgi fragmentation
tential Cdc2 sites not present in the rat sequence (Ser-in anthrax toxin±treated cells was studied by immunoflu-
53 and Thr-57). Whether these residues, both locatedorescence and electron microscopy (see Figures 7C and
outside the p115-binding site, can be mitotically phos-7D). Inactivation of MEK1 by anthrax toxin had no effect
phorylated and play a role in regulating binding to p115upon mitotic entry (Figure 7B), nor upon mitotic Golgi
must await further experiments.fragmentation. One hundred percent of anthrax toxin±
Many of the putative physiological substrates of Cdc2treated metaphase cells had a fragmented Golgi, com-
are involved in maintaining organellar and cellular archi-pared to 99% of control metaphase cells (n 5 100 cells).
tecture (e.g., lamins of the nuclear matrix, vimentin onThe average VD of mitotic Golgi clusters from untreated
intermediate filaments) (see Nigg, 1995). GM130 is thecells was 0.0024 6 0.0019 and from anthrax toxin±
first Golgi protein to be identified as a substrate for
treated cells was 0.0024 6 0.0014. Together, the experi-
Cdc2. Cdc2-mediated phosphorylation of GM130 is
ments with PD and anthrax toxin demonstrate that MEK1
probably an important step in the mitotic fragmentation
is not required for mitotic Golgi fragmentation in vivo,
of the Golgi complex. It is one of the most highly phos-
consistent with the results from our in vitro system.
phorylated Golgi proteins in mitosis (Barr et al., 1997;
data not shown). Phosphorylation inhibits binding to
the vesicle-docking protein p115, and this has beenDiscussion
proposed to prevent docking of COPI vesicles with Golgi
cisternae, leading to the cessation of membrane trans-
Several lines of evidence strongly suggest that GM130
port and ultimately the COPI-mediated pathway of frag-
is a physiological substrate for Cdc2. First, depletion of
mentation, the major mitotic Golgi fragmentation path-
Cdc2 from mitotic cytosol almost completely abolished
way in vitro (Misteli and Warren, 1994; Nakamura et al.,
phosphorylation of a synthetic peptide corresponding 1997). A reasonable model is therefore that phosphory-
to the N-terminal 73 amino acids of GM130 as well as lation of Ser-25 by Cdc2 initiates the sequence of events
phosphorylation of the native, full-length protein. Phos- leading to the COPI pathway of mitotic Golgi fragmen-
phorylation was restored when purified cyclin B±Cdc2 tation.
was added back to the same level as mitotic cytosol, The other mitotic fragmentation pathway does not
arguing against the possibility that another GM130 involve COPI.Cisternae become unstacked and the core
kinase was somehow inactivated or depleted by the region appears to break down to form tubular networks
anti-Cdc2 antibody coupled beads. Second, purified re- that fragment further, yielding heterogenous tubules and
combinant cyclin B±Cdc2 phosphorylated the GM130 vesicles larger in size than COPI vesicles (Misteli and
peptide and native, full-length GM130 to a similar extent Warren, 1995b). Cdc2 is also involved in this pathway,
as mitotic cytosol, while the related Cdk2 kinase did not. since unstacking was also inhibited when mitotic cytosol
Third, GM130 was phosphorylated by cyclin B±Cdc2 at was depleted of Cdc2 (not shown). That is not to say,
the same site in vitro as that phosphorylated in vivo. however, that Cdc2 is the only kinase involved in mitotic
Fourth, GM130 is phosphorylated only in mitosis when Golgi fragmentation. It is possible that another kinase
cyclin B±Cdc2 is active. Although we cannot entirely tightly associated with Golgi membranes is activated
exclude the possibility that another, perhaps related, by Cdc2 and plays some role in fragmentation. Other
kinase might carry out the GM130 phosphorylation in kinases could also be involved in aspects of the frag-
vivo, the combined data strongly suggest that Cdc2 is mentation process that occur in vivo that we have failed
the GM130 kinase. to reconstitute in the cell-free assay. For example, the
Ser-25 was identified as the major GM130 mitotic earliest event of fragmentation in vivo, the breakdown
phosphorylation site using a combination of peptide of the Golgi ribbon to form discrete stacks, is not re-
mapping and mass spectrometry. The importance of constituted in our cell-free assay, which starts with the
Ser-25 in regulating binding to p115 was confirmed by discrete stacks themselves. Another kinase might be
mutational analysis. Mutation of Ser-25 to mimic phos- involved in this or perhaps other steps in vivo. Inter-
estingly, it has recently been reported that MEK1 isphorylation inhibited binding to p115, while mutation to
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MEK1 (C-18; Santa-Cruz), and N terminus of MEK1 (662; kindlythe kinase responsible for mitotic Golgi fragmentation
provided by Dr. J. Ferrell). Activated MEK1 and recombinant ERK2(Acharya et al., 1998). It was proposed that MEK1 func-
were kindly provided by Drs. C. Smythe and D. Alessi. Anthrax toxintions downstream of Cdc2 and acts through a novel
was kindly provided by Dr. C. Montecucco.
Golgi-associated ERK to bring about fragmentation.
This was discovered using a morphological assay based Immunodepletion of Kinases from Mitotic Cytosol
upon addition of mitotic cytosol to permeabilized cells. Mitotic HeLa cytosol (Stuart et al., 1993) was desalted into buffer A
(20 mM b-glycerophosphate, 15 mM EGTA, 50 mM KOAc, 10 mMFragmentation was observed by immunofluorescence
MgOAc, 2 mM ATP, 1mM DTT). Three hundred microliters of cytosolstaining of a Golgi marker, which changed from a perinu-
(10±12 mg/ml) was incubated with antibody-coupled beads (45 mgclear ribbon into many small punctate structures scat-
antibodies against Cdc2, Cdk2, or MEK1 [C-18] on 50 ml protein
tered throughout the cell (Acharya et al., 1998). Frag- A±sepharose) for 1 hr at 48C, the beads removed by centrifugation,
mentation occurred in the absence of Cdc2, while and another 50 ml beads added for an additional 1 hr at 48C. The
addition of the MEK1-inhibitor PD or depletion of MEK1 beads were removed and the supernatants stored at 2808C.
from cytosolwas found to inhibit the process (Acharya et
Production and Purification of CDKsal., 1998). However, no electron microscopical evidence
Cyclins and CDKs were coexpressed in baculovirus-infected cellswas provided that the scattered Golgi structures were
as described previously (Krude et al., 1997).
true mitotic clusters. This is particularly important, since
at the level of immunofluorescence microscopy it is im- Histone Kinase Assay
possible to distinguish Golgi stacks from Golgi clusters One microliter of sample was added to 10 ml buffer A containing 2
mg/ml histone H1 and 0.1 mCi/ml [g-32P]ATP and incubated for 30(Shima et al., 1997), and it is therefore unclear if a genu-
min at 308C. Five microliters was spotted onto P81 paper (Whatman)ine mitotic fragmentation process was being analyzed.
and washed four times with 150 mM phosphoric acid and onceUsing our cell-free mitotic fragmentation assay based
with 95% ethanol. After drying, samples were subjected to liquidupon electron microscopical analyses of the conversion
scintillation counting.
of Golgi cisternae to small vesicles and tubules (Misteli
and Warren, 1994), we could find no evidence of a re- In Vitro Phosphorylations
quirement for MEK1. Inhibition of MEK1 with PD, deple- N73pep, in vitro±synthesized GM130, or salt-washed Golgi mem-
branes (Levine et al., 1996) were incubated in buffer A with mitotiction of MEK1, or addition of active MEK1 had no effect
cytosol (2±10 mg/ml) or purified kinase for 10±30 min at 308C. Inupon GM130 phosphorylation or Golgi fragmentation.
some experiments, 0.2±40 mCi/ml [g-32P]ATP was present. ReactionsWe also found that MEK1 activity was relatively low
were terminated by boiling in sample buffer for SDS-PAGE or byin prometaphase/metaphase cells (about 15-fold lower
adding HKT containing 25 mM staurosporine and 10 mM microcystin-
specific activity than serum-stimulated cells [not shown] LR for p115 bead binding experiments. For immunoprecipitation
and 2.5-fold lower than interphase cells). This is consis- experiments, reactions were terminated by adding SDS buffer (20
tent with a previous report that MEK1 is inhibited in mM HEPES [pH 7.4], 0.2 M NaCl, 1% SDS, 2 mM EDTA, 1 mM DTT)
containing protease inhibitors (PI). Immunoprecipitation of GM130somatic cells during mitosis due to phosphorylation by
and binding of GM130 to p115 beads were performed as describedCdc2 (Rossomando et al., 1994) and agrees well with
(Nakamura et al., 1997).studies from a number of labs demonstrating low ERK
activity in mitotic somatic cells (Heider et al., 1994; Edel- Cell Culture, Drug Treatments, and Lysate Preparation
mann et al., 1996; Takenaka et al., 1998). The low MEK1 For enrichment of mitotic NRK cells, 2.5 mg/ml aphidicolin was
activity in mitosis is consistent with MEK1 not being a added to the medium for 14 hr and the cells released from the S
phase block by washing into fresh medium. One hour after release,key mitotic regulator of Golgi fragmentation.
cells were exposed to 60 mM roscovitine (Calbiochem), 50 mMSince it is always difficult to compare different in vitro
PD98059 (New England Biolabs), or anthrax toxin (1 mg/ml PA plussystems and to know to what extent the results can be
250 ng/ml LF). Cells were cultured for various times before fixationextrapolated to intact cells, we decided to block MEK1
for microscopy or lysis. Cells were rinsed with ice-cold PBS before
function in vivo. First, the specific inhibitor PD98059 was addition of lysis buffer (20 mM HEPES [pH 7.4], 100 mM KCl, 10%
added to cells to inactivate MEK1, and mitotic Golgi glycerol, 0.5% Triton X-100, 5 mM EDTA, 2 mM EGTA, 10 mM NaF,
fragmentation was then studied. PD did inhibit MEK1 40 mM b-glycerophosphate, 1 mM sodium orthovanadate, 1 mM
DTT) containing PI. After 10 min at 48C, lysates were clarified byactivity but had no effect upon mitotic Golgi fragmenta-
centrifugation and stored at 2808C.tion at the level of both immunofluorescence and elec-
tron microscopy. To eliminate completely the possibility
MEK1 Assay
that sufficient MEK1 activity remained during PD treat- Cytosol (20±50 mg) was diluted into 50 ml lysis buffer and incubated
ment to cause fragmentation, we took advantage of with anti-MEK1 beads (2 ml 662 or 2 mg C-18 antibodies on 5 ml
the recent finding that MEK1 can be quantitively and protein A±sepharose) for 1 hr at 48C. The beads were washed twice
with lysis buffer containing 0.5 M NaCl and once with kinase bufferirreversibly inactivated by proteolytic degradation in
(40 mM HEPES [pH 7.4], 10 mM MgCl2, 250 mM ATP, 1 mM DTT)vivo by anthrax toxin (Duesbery et al., 1998). Treatment
before incubation with 25 ml kinase buffer containing 0.5 mg ERK2of cells with anthrax toxin cleaved all of the cellular
(in the presence or absence of PD) for 30 min at 308C. The beadsMEK1 but had no effect upon mitotic Golgi fragmenta-
were removed by centrifugation and 10 ml of the supernatant incu-
tion. Taking all the data together, we conclude that mi- bated with 10 ml kinase buffer containing 10 mg MBP and 1 mCi/ml
totic Golgi fragmentation is dependent upon Cdc2 and [g-32P]ATP for another 30 min at 308C. Five microliters was spotted
independent of MEK1. onto P81 paper and processed for liquid scintillation counting.
Immunofluorescence and Electron MicroscopyExperimental Procedures
of Drug-Treated Mitotic Cells
Cells were fixed and stained for immunofluorescence microscopyReagents and Antibodies
as described (Shima et al., 1997). For electron microscopy, mitoticThe following antibodies were used: phosphorylated ERK (New En-
gland Biolabs), Cdk2 and Cdc2 (Upstate Biotech.), C terminus of cells were flushed from the dish, fixed in 2% gluteraldehyde in PBS
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for 30 min on ice, and processed for electron microscopy according 1) is required for Golgi fragmentation during mitosis. Cell 92,
183±192.to Misteli and Warren (1994). Stereology was performed on ten
untreated, PD-, or anthrax-treated metaphase cells. Mitotic Golgi Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T., and Saltiel, A.R.
clusters were defined according to Misteli and Warren (1995a). The (1995). PD 098059 is a specific inhibitor of the activation of mitogen-
cell and Golgi cluster volume was estimated by the point-hit method activated protein kinase in vitro and in vivo. J. Biol. Chem. 270,
using a 1 cm grid and 7,600X magnification for Vcell and a 2 mm grid 27489±27494.
and 22,960X magnification for Vclust. Vclust-tot was the sum of volumes Barr, F.A., Puype, M., Vandekerckhove, J., and Warren, G. (1997).
of individual clusters in one cell section. The VD of clusters is ex- GRASP65, a protein involved in the stacking of Golgi cisternae. Cell
pressed as Vclust-tot/Vcell. Values are expressed as the average 6 SD 91, 253±262.
(n 5 10 cells).
Barroso, M., Nelson, D.S., and Sztul, E. (1995). Transcytosis-associ-
ated protein (TAP)/p115 is a general fusion factor required for bind-
In Vivo Metabolic Labeling and Immunoprecipitation ing of vesicles to acceptor membranes. Proc. Natl. Acad. Sci. USA
of GM130 92, 527±531.
NRK cells were released from an aphidicolin block for 2 hr and
Boyle, W.J., Van der Geer, P., and Hunter, T. (1991). Phosphopeptidelabeled with 200 mCi/ml [32P]orthophosphate for another 3 hr at 378C.
mapping and phosphoamino acid analysis by two-dimensional sep-Mitotic cells were flushed from the dish and extracted with lysis
aration on thin layer cellulose plates. Methods Enzymol. 201,buffer containing PI for 15 min on ice. The lysate was cleared by
110±149.
centrifugation and GM130 immunoprecipitated as described (Naka-
Cao, X., Ballew, N., and Barlowe, C. (1998). Initial docking of ER-mura et al., 1997).
derived vesicles requires Uso1p and Ypt1p but is independent of
SNARE proteins. EMBO J. 17, 2156±2165.SDS-PAGE, Western, and Far Western Blotting
Dudley, D.T., Pang, L., Decker, S.J., Bridges, A.J., and Saltiel, A.R.SDS-PAGE, Western, and Far Western blotting were performed as
(1995). A synthetic inhibitor of the mitogen-activated protein kinasedescribed (Nakamura et al., 1997).
cascade. Proc. Natl. Acad. Sci. USA 92, 7686±7689.
Duesbery, N.S., Webb, C.P., Leppla, S.H., Gordon, V.M., Klimpel,Phosphopeptide Analysis and Mass Spectrometry
K.R., Copeland, T.D., Ahn, N.G., Oskarsson, M.K., Fukasawa, K.,Two-dimensional phosphoamino acid and phosphopeptide analysis
Paull, K.D., et al. (1998). Proteolytic inactivation of MAP-kinase-was performed according to Boyle et al. (1991). For mass spectrom-
kinase by anthrax lethal factor. Science 280, 734±737.etry, N73pep was subjected to SDS-PAGE, transferred to PVDF
Edelmann, H.M., Kuhne, C., Petritsch, C., and Ballou, L.M. (1996).membrane, and the band excised before digestion overnight with
Cell cycle regulation of p70 S6 kinase and p42/p44 mitogen-acti-trypsin or V8 protease. Proteolytic fragments released from the
vated protein kinases in Swiss mouse 3T3 fibroblasts. J. Biol. Chem.PVDF membrane were analyzed by laser desorption mass spectrom-
271, 963±971.etry (Pappin et al., 1993).
Guadagno, T.M., and Newport, J.W. (1996). Cdk2 kinase is required
for entry into mitosis as a positive regulator of Cdc2±cyclin B kinaseCell-Free Golgi Disassembly Assay
activity. Cell 84, 73±82.Cytosols (10 mg/ml in buffer A) were supplemented with 0.25 M
sucrose and an ATP-regenerating system and clarified by centrifu- Heider, H., Hug, C., and Lucocq, J.M. (1994). A 40-kDa myelin basic
protein kinase, distinct from erk1 and erk2, is activated in mitoticgation at 20,000 3 g for 5 min. Cytosol was sometimes preincubated
HeLa cells. Eur. J. Biochem. 219, 513±520.for 10 min at 378C with PD before preclearing. Cytosol (65 ml) was
added to 3 ml (10 mg) of Golgi membranes and incubated at 378C Holmes, J.K., and Solomon, M.J. (1996). A predictive scale for evalu-
for 30 min. Membranes were recovered by centrifugation, fixed, and ating cyclin-dependent kinase substrates. J. Biol. Chem. 271,
processed for electron microscopy as described previously (Misteli 25240±25246.
and Warren, 1994). Cisternae were defined as membrane profiles Krude, T., Jackman, M., Pines, J., and Laskey, R.A. (1997). Cyclin/
with a length greater than four times their width, which was not Cdk-dependent initiation of DNA replication in a human cell-free
greater than 80 nm. The percentage of membranes in cisternae was system. Cell 88, 109±119.
determined by the intersection method. Levine, T.P., Rabouille, C., Kieckbusch, R.H., and Warren, G. (1996).
Binding of the vesicle docking protein p115 to Golgi membranes is
Plasmid Construction inhibited under mitotic conditions. J. Biol. Chem. 271, 17304±17311.
Point mutations were introduced into the GM130DC436 cDNA con- Mackay,D., Kieckbusch,R., Adamczewski, J., andWarren, G. (1993).
struct in pBSIIKS1 (Nakamura et al., 1997) by PCR, using the Quick- Cyclin A-mediated inhibition of intra-Golgi transport requires
change mutagenesis kit (Stratagene) according to the manufactur- p34(cdc2). FEBS Lett. 336, 549±554.
er's instructions. All clones were verified by DNA sequencing.
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